Shoulder Flexibility and Breast Augmentation Surgery: Randomized Study

Shoulder range of motion and breast augmentation: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

REBEC

Registry ID

RBR-3yryp6x

Enrollment

Registered

2026-04-22

Start date

2024-01-05

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bursitis, cicatrix Surgery, Plastic

Interventions

This is a triple-blind randomized controlled clinical trial (surgeon, clinical and statistician evaluators) involving patients who underwent silicone implant placement with or without mastopexy. Expe

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Women aged 18 to 60 years; surgical indication for breast augmentation associated with breast ptosis correction

Exclusion criteria

Exclusion criteria: Current or previous breast cancer diagnosis; diabetes mellitus; hypothyroidism; history of previous breast surgeries; including prior mammoplasties of any nature

Design outcomes

Primary

Measure	Time frame
Expected outcome 1: Passive range of motion of the shoulders after breast augmentation: a difference of at least 20° in range of motion is expected, with greater anterior shoulder flexion in the experimental group compared to the control group.;Outcome found 1: There were no differences between the groups or in the Group × Time interaction in the passive range of motion of the shoulders	—

Secondary

Measure	Time frame
Expected outcome 2: Surgical scar quality: it is expected that the quality of the surgical scar will be similar between the two groups.;Outcome found 2: there was no difference in scar quality between groups.;Expected outcome 3: Seroma volume after mammaplasty: it is expected that the seroma volume will be similar between the groups;Outcome found 3: The volume of seroma after the surgery showed a reduction in the volume between T4 and T24 on both sides. There was no difference between the groups;Expected outcome 4: Adhesive capsulitis and/or pain with anterior shoulder flexion: it is expected that adhesive capsulitis will occur less frequently in the experimental group than in the control group.	—

Measure

Time frame

Expected outcome 2: Surgical scar quality: it is expected that the quality of the surgical scar will be similar between the two groups.;Outcome found 2: there was no difference in scar quality between groups.;Expected outcome 3: Seroma volume after mammaplasty: it is expected that the seroma volume will be similar between the groups;Outcome found 3: The volume of seroma after the surgery showed a reduction in the volume between T4 and T24 on both sides. There was no difference between the groups;Expected outcome 4: Adhesive capsulitis and/or pain with anterior shoulder flexion: it is expected that adhesive capsulitis will occur less frequently in the experimental group than in the control group.

—

Countries

Contacts

Public ContactMarcelo Prado

Universidade Federal de Goiás

cliniquegoiania@gmail.com+55 (62) 3521-1000

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Jun 29, 2026